Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems

Detalhes bibliográficos
Autor(a) principal: Olim, Filipe
Data de Publicação: 2020
Outros Autores: Neves, Ana Rute, Wang, Zhao, Sun, Jingjing, Tomás, Helena, Sheng, Ruilong
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.13/3820
Resumo: Using natural lipids to covalently connect with antitumor agents to construct lipid-based molecular prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry, nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin (molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally, possible future research outlooks in this field were also discussed.
id RCAP_8dfcb130f91af5fc31050091d72e62d5
oai_identifier_str oai:digituma.uma.pt:10400.13/3820
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systemsLipidDoxorubicinProdrugsStimuli-responsiveDrug co-deliveryNanosystems.Faculdade de Ciências Exatas e da EngenhariaCentro de Química da MadeiraUsing natural lipids to covalently connect with antitumor agents to construct lipid-based molecular prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry, nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin (molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally, possible future research outlooks in this field were also discussed.Medicine ResearchDigitUMaOlim, FilipeNeves, Ana RuteWang, ZhaoSun, JingjingTomás, HelenaSheng, Ruilong2021-11-16T14:22:44Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.13/3820engOlim, F., Neves, A. R., Wang, Z., Sun, J., Tomás, H., & Sheng, R. (2020). Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems. Medicine Research, 4(1-2), 200013. DOI: 10.21127/yaoyimr2020001310.21127/yaoyimr20200013info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-10T06:27:04Zoai:digituma.uma.pt:10400.13/3820Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:07:16.294957Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
title Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
spellingShingle Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
Olim, Filipe
Lipid
Doxorubicin
Prodrugs
Stimuli-responsive
Drug co-delivery
Nanosystems
.
Faculdade de Ciências Exatas e da Engenharia
Centro de Química da Madeira
title_short Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
title_full Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
title_fullStr Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
title_full_unstemmed Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
title_sort Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
author Olim, Filipe
author_facet Olim, Filipe
Neves, Ana Rute
Wang, Zhao
Sun, Jingjing
Tomás, Helena
Sheng, Ruilong
author_role author
author2 Neves, Ana Rute
Wang, Zhao
Sun, Jingjing
Tomás, Helena
Sheng, Ruilong
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv DigitUMa
dc.contributor.author.fl_str_mv Olim, Filipe
Neves, Ana Rute
Wang, Zhao
Sun, Jingjing
Tomás, Helena
Sheng, Ruilong
dc.subject.por.fl_str_mv Lipid
Doxorubicin
Prodrugs
Stimuli-responsive
Drug co-delivery
Nanosystems
.
Faculdade de Ciências Exatas e da Engenharia
Centro de Química da Madeira
topic Lipid
Doxorubicin
Prodrugs
Stimuli-responsive
Drug co-delivery
Nanosystems
.
Faculdade de Ciências Exatas e da Engenharia
Centro de Química da Madeira
description Using natural lipids to covalently connect with antitumor agents to construct lipid-based molecular prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry, nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin (molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally, possible future research outlooks in this field were also discussed.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2021-11-16T14:22:44Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.13/3820
url http://hdl.handle.net/10400.13/3820
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Olim, F., Neves, A. R., Wang, Z., Sun, J., Tomás, H., & Sheng, R. (2020). Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems. Medicine Research, 4(1-2), 200013. DOI: 10.21127/yaoyimr20200013
10.21127/yaoyimr20200013
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Medicine Research
publisher.none.fl_str_mv Medicine Research
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799129942789718016

Registros relacionados